Biosino Bio-Technology and Science Incorporation (HKG:8247)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.480
+0.020 (0.58%)
At close: Apr 20, 2026

HKG:8247 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
184.29263.07289.07373.07348.23
Revenue Growth (YoY)
-29.95%-9.00%-22.52%7.13%7.06%
Cost of Revenue
113.37154.67161.71226.79204.63
Gross Profit
70.92108.4127.37146.28143.59
Selling, General & Admin
93.27106.6110.499.6793.27
Research & Development
26.8233.4235.8126.8724.94
Operating Expenses
124.76145.69146.78126.54118.22
Operating Income
-53.84-37.29-19.4119.7425.38
Interest Expense
-6.81-9.3-6.4-6.82-10.57
Interest & Investment Income
1.561.660.330.340.22
Earnings From Equity Investments
0.1-0.4212.356.531.57
Other Non Operating Income (Expenses)
-3.75-1.41-3.88-1.08-10.07
EBT Excluding Unusual Items
-62.75-46.75-17.0218.716.54
Asset Writedown
-4.5-12.97-0.59-0.19-0.13
Pretax Income
-67.25-59.72-17.6118.526.41
Income Tax Expense
-2.23-2.831.634.313.25
Earnings From Continuing Operations
-65.02-56.89-19.2414.23.16
Minority Interest in Earnings
13.8814.367.59-6.1-4.3
Net Income
-51.14-42.53-11.658.11-1.14
Net Income to Common
-51.14-42.53-11.658.11-1.14
Shares Outstanding (Basic)
145145145145145
Shares Outstanding (Diluted)
145145145145145
EPS (Basic)
-0.35-0.29-0.080.06-0.01
EPS (Diluted)
-0.35-0.29-0.080.06-0.01
Free Cash Flow
-32.3911.36-22.9128.1945.15
Free Cash Flow Per Share
-0.220.08-0.160.200.31
Gross Margin
38.48%41.21%44.06%39.21%41.23%
Operating Margin
-29.22%-14.17%-6.72%5.29%7.29%
Profit Margin
-27.75%-16.17%-4.03%2.17%-0.33%
Free Cash Flow Margin
-17.57%4.32%-7.92%7.56%12.97%
EBITDA
-38.14-22.7-2.3540.9249.93
EBITDA Margin
-20.69%-8.63%-0.81%10.97%14.34%
D&A For EBITDA
15.714.5917.0621.1824.55
EBIT
-53.84-37.29-19.4119.7425.38
EBIT Margin
-29.22%-14.17%-6.72%5.29%7.29%
Effective Tax Rate
---23.30%50.68%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.